Early intervention in the 3xTg-AD mice with an amyloid β-antibody fragment ameliorates the first hallmarks of Alzheimer’s disease (60), and inhibits tau phosphorylation from slowing the progression of dementia (60). This evidence concerns the gene MAPT and Alzheimer disease.